目的利用三色流式细胞术对急性淋巴细胞白血病(all)免疫表型跨系表达进行研究。
Objective to study the cross-lineage expression of acute lymphoblastic leukemia (ALL) with the use of multi-parameter flow cytometry in the immunophenotype of ALL.
目的了解多中心协作化疗方案(MCP方案)对急性淋巴细胞白血病(all)和非霍奇金淋巴瘤(NHL)患儿肾脏功能的影响。
Objective to investigate the renal damages in children with acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma (NHL) who received the intensive multicenter-protocols (MCP).
氯法拉滨注射液适用于对至少2种治疗方案无效的儿童(1 - 21岁)难治性或复发性急性淋巴细胞白血病的治疗。
Clofarabine injection is indicated for the treatment of pediatric patients (ages 1-21 years) with relapsed or refractory acute lymphoblastic leukemia after at least 2 previous regimens.
目的：通过血药浓度监测，提高对小儿急性淋巴细胞白血病大剂量甲氨蝶呤化疗的有效性和安全性。
OBJECTIVE: to improve the efficacy and safety of high dose methotrexate (HDMTX) chemotherapy in the treatment of children with acute lymphoblastic leukemia through blood concentration monitoring.
目的探讨急性淋巴细胞白血病误诊为风湿病的原因，提高对其认识以便于早期诊断。
To explore the reason of misdiagnosis of acute lymphatic leukemia as rheumatic disease and improve the cognition for early diagnosis.
本文对29例急性非淋巴细胞白血病(ANLL)患者的血浆血栓调节蛋白(TM)水平进行检测，发现ANLL组血浆TM水平比正常组明显升高。
The plasma concentration of thrombomodulin (TM) were measured in 29 cases of acute non-lymphocytic leukemia (ANLL). Plasma TM level significantly increased in ANLL patients.
目的对15 8例儿童急性淋巴细胞白血病（ALL）患儿治疗结果进行分析，探讨如何进一步提高儿童ALL无事件生存（EFS）率。
Objective To analyse the treatment outcome of 158 childhood acute lymphoblastic leukemia (ALL) patients, and explore how to improve the event-free survival(EFS) rate in ALL.
目的对15 8例儿童急性淋巴细胞白血病（ALL）患儿治疗结果进行分析，探讨如何进一步提高儿童ALL无事件生存（EFS）率。
Objective To analyse the treatment outcome of 158 childhood acute lymphoblastic leukemia (ALL) patients, and explore how to improve the event-free survival(EFS) rate in ALL.
应用推荐